277 related articles for article (PubMed ID: 22040803)
1. MVP and vaults: a role in the radiation response.
Lara PC; Pruschy M; Zimmermann M; Henríquez-Hernández LA
Radiat Oncol; 2011 Oct; 6():148. PubMed ID: 22040803
[TBL] [Abstract][Full Text] [Related]
2. Cellular functions of vaults and their involvement in multidrug resistance.
Steiner E; Holzmann K; Elbling L; Micksche M; Berger W
Curr Drug Targets; 2006 Aug; 7(8):923-34. PubMed ID: 16918321
[TBL] [Abstract][Full Text] [Related]
3. Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP.
Mikyas Y; Makabi M; Raval-Fernandes S; Harrington L; Kickhoefer VA; Rome LH; Stewart PL
J Mol Biol; 2004 Nov; 344(1):91-105. PubMed ID: 15504404
[TBL] [Abstract][Full Text] [Related]
4. Vaults: a ribonucleoprotein particle involved in drug resistance?
Mossink MH; van Zon A; Scheper RJ; Sonneveld P; Wiemer EA
Oncogene; 2003 Oct; 22(47):7458-67. PubMed ID: 14576851
[TBL] [Abstract][Full Text] [Related]
5. Vaults and the major vault protein: novel roles in signal pathway regulation and immunity.
Berger W; Steiner E; Grusch M; Elbling L; Micksche M
Cell Mol Life Sci; 2009 Jan; 66(1):43-61. PubMed ID: 18759128
[TBL] [Abstract][Full Text] [Related]
6. Major vault protein forms complexes with hypoxia-inducible factor (HIF)-1alpha and reduces HIF-1alpha level in ACHN human renal adenocarcinoma cells.
Iwashita K; Ikeda R; Takeda Y; Sumizawa T; Furukawa T; Yamaguchi T; Akiyama S; Yamada K
Cancer Sci; 2010 Apr; 101(4):920-6. PubMed ID: 20175781
[TBL] [Abstract][Full Text] [Related]
7. The formation of vault-tubes: a dynamic interaction between vaults and vault PARP.
van Zon A; Mossink MH; Schoester M; Houtsmuller AB; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
J Cell Sci; 2003 Nov; 116(Pt 21):4391-400. PubMed ID: 13130096
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance.
Siva AC; Raval-Fernandes S; Stephen AG; LaFemina MJ; Scheper RJ; Kickhoefer VA; Rome LH
Int J Cancer; 2001 Apr; 92(2):195-202. PubMed ID: 11291045
[TBL] [Abstract][Full Text] [Related]
9. Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes.
Zheng CL; Sumizawa T; Che XF; Tsuyama S; Furukawa T; Haraguchi M; Gao H; Gotanda T; Jueng HC; Murata F; Akiyama S
Biochem Biophys Res Commun; 2005 Jan; 326(1):100-7. PubMed ID: 15567158
[TBL] [Abstract][Full Text] [Related]
10. Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer.
Scheffer GL; Schroeijers AB; Izquierdo MA; Wiemer EA; Scheper RJ
Curr Opin Oncol; 2000 Nov; 12(6):550-6. PubMed ID: 11085454
[TBL] [Abstract][Full Text] [Related]
11. Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression.
Lara PC; Lloret M; Clavo B; Apolinario RM; Henríquez-Hernández LA; Bordón E; Fontes F; Rey A
Radiat Oncol; 2009 Aug; 4():29. PubMed ID: 19660100
[TBL] [Abstract][Full Text] [Related]
12. Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer.
Szaflarski W; Sujka-Kordowska P; Pula B; Jaszczyńska-Nowinka K; Andrzejewska M; Zawierucha P; Dziegiel P; Nowicki M; Ivanov P; Zabel M
Int J Oncol; 2013 Aug; 43(2):513-20. PubMed ID: 23739867
[TBL] [Abstract][Full Text] [Related]
13. Analysis of MVP and VPARP promoters indicates a role for chromatin remodeling in the regulation of MVP.
Emre N; Raval-Fernandes S; Kickhoefer VA; Rome LH
Biochim Biophys Acta; 2004 Apr; 1678(1):33-46. PubMed ID: 15093136
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of major vault protein during the life cycle of the human parasite Schistosoma mansoni.
Reis EV; Pereira RV; Gomes M; Jannotti-Passos LK; Baba EH; Coelho PM; Mattos AC; Couto FF; Castro-Borges W; Guerra-Sá R
Parasitol Int; 2014 Feb; 63(1):120-6. PubMed ID: 24148287
[TBL] [Abstract][Full Text] [Related]
15. vPARP Adjusts MVP Expression in Drug-resistant Cell Lines in Conjunction with MDR Proteins.
Wojtowicz K; Januchowski R; Nowicki M; Zabel M
Anticancer Res; 2017 Jun; 37(6):3015-3023. PubMed ID: 28551640
[TBL] [Abstract][Full Text] [Related]
16. [The structure of cellular vaults, their role in the normal cell and in the multidrug resistance of cancer].
Szaflarski W; Nowicki M; Zabel M
Postepy Biochem; 2011; 57(3):266-73. PubMed ID: 22235652
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Major Vault Protein (MVP) and Cellular Vault Particles in Fish.
Margiotta AL; Bain LJ; Rice CD
Anat Rec (Hoboken); 2017 Nov; 300(11):1981-1992. PubMed ID: 28710803
[TBL] [Abstract][Full Text] [Related]
18. The La RNA-binding protein interacts with the vault RNA and is a vault-associated protein.
Kickhoefer VA; Poderycki MJ; Chan EK; Rome LH
J Biol Chem; 2002 Oct; 277(43):41282-6. PubMed ID: 12196535
[TBL] [Abstract][Full Text] [Related]
19. MVP Expression Facilitates Tumor Cell Proliferation and Migration Supporting the Metastasis of Colorectal Cancer Cells.
Pietras P; Leśniczak-Staszak M; Kasprzak A; Andrzejewska M; Jopek K; Sowiński M; Rucinski M; Lyons SM; Ivanov P; Szaflarski W
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829999
[TBL] [Abstract][Full Text] [Related]
20. Vaults are up-regulated in multidrug-resistant cancer cell lines.
Kickhoefer VA; Rajavel KS; Scheffer GL; Dalton WS; Scheper RJ; Rome LH
J Biol Chem; 1998 Apr; 273(15):8971-4. PubMed ID: 9535882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
